This activity has been designed to meet the educational needs of pulmonologists, radiologists, and pathologists. It may also be of benefit to primary care physicians, rheumatologists, PAs, nurse practitioners, nurses, pharmacists, fellows, residents, and other healthcare professionals who care for patients with chronic progressive fibrosing interstitial lung disease (PF-ILD).
Progressive fibrosing ILD occurring in patients with RA significantly increases mortality risk. Anti-inflammatory and antifibrotic agents may be used to treat RA-ILD.
Upon completion of this activity, participants should be better able to: